2014 RDCR SYMPOSIUM AGENDA

Transcription

1 2014 RDCR SYMPOSIUM AGENDA MONDAY 1300 SESSION 1: RDCR NEEDS ASSESSMENT Introduction / Moderator Geir Strandenes, MD Senior Medical Officer Norwegian Naval Special Operation Commando Researcher, Department of Immunology and Transfusion Medicine Haukeland University Hospital RDCR Research, Development, and Acquisition within the US Department of Defense retired COL Kenneth Bertram, MD Principal Assistant for Acquisition US Army Medical Research and Materiel Command Fort Detrick, Maryland USA The impact of observational and retrospective research LTC(P) Jeremy Perkins, MD FACP Chief, Hematology-Oncology Service US Army, Medical Corps Walter Reed National Military Medical Center Military RDCR Needs Naval Special Warfare Command Speaker - TBD Civilian RDCR Needs Norwegian EMS Speaker TBD BREAK MEDIC WORKSHOP 1500 SESSION 2: OPTIMAL RESUSCITATION STRATEGIES Moderator: Kevin Ward, MD Professor, Department of Emergency Medicine University of Michigan Michigan Center for Integrative Research in Critical Care (MCIRCC) Ann Arbor, Michigan USA The Optimal Resuscitation Strategy for the Primary Coagulopathy of Trauma is whole blood based LTC Andrew P. Cap, MD, PhD, FACP Chief, Coagulation and Blood Research Director, Clinical Research Fellowship Program US Army Institute of Surgical Research Medical Corps, US Army San Antonio, Texas USA Page 1 1/7/14

2 The Optimal Resuscitation Strategy for the Primary Coagulopathy of Trauma is targeted therapy Karim Brohi, MD Professor of Trauma Sciences Barts and the London School of Medicine Consultant in Trauma & Vascular surgery, Royal London Hospital London, UK Debate / Discussion Moderator: Kevin Ward, MD Professor, Department of Emergency Medicine University of Michigan Michigan Center for Integrative Research in Critical Care (MCIRCC) Ann Arbor, Michigan USA BREAK 1630 SESSION 3: POC RDCR NEEDS AND TCCC/TECC UPDATE Moderator: LTC Elon Glassberg, MD Head, the Trauma and Combat Medicine Branch, IDF-MC Israel Defense Forces Medical Corps Tel HaShomer, Israel Pre-Hospital POC Monitory/ Goal Directed Therapy-Debate: Does it Make a Difference? Christine Gaarder, MD Head of Trauma Unit, Department of Traumatology Division of Emergency and Critical Care Oslo University Hospital Oslo, Norway TCCC /TECC Update Frank Butler, MD Chairman - Committee on Tactical Combat Casualty Care Joint Trauma System Joint Base San Antonio, Texas USA BREAK Avoiding the Complications of Transfusion Support While Preserving Benefit: Applications of Pathogen Reduction Technology Raymond Goodrich, PhD Chief Sciences Officer / Blood Bank Technologies TerumoBCT Denver, Colorado USA 2000 DINNER Page 2 1/7/14

3 TUESDAY 0900 SESSION 4: ENDOTHELIOPATHY OF TRAUMA Moderator: Karim Brohi, MD Professor of Trauma Sciences Barts and the London School of Medicine Consultant in Trauma & Vascular surgery, Royal London Hospital London, UK Pathophysiology of Endotheliopathy Trauma Shibani Pati, MD, PhD Assistant Professor Blood Systems Research Institute Department of Laboratory Medicine University of California San Francisco, California USA Treatment Strategies for the Endotheliopathy Trauma Rosemary Kozar, MD, PhD Professor of Surgery and Chief of Trauma Memorial Hermann Hospital University of Texas Medical School at Houston Houston, Texas USA Moderator led Discussion Karim Brohi, MD Professor of Trauma Sciences Barts and the London School of Medicine Consultant in Trauma & Vascular surgery, Royal London Hospital London, UK MEDIC WORKSHOP BREAK 1030 SESSION 5: PLASMA EFFICACY AND SAFETY Moderator: ret COL Donald Jenkins, MD Consultant, Division of Trauma, Critical Care and General Surgery Associate Professor of Surgery Trauma Medical Director Saint Mary s Hospital, Mayo Clinic Rochester, Minnesota USA Plasma Product Differences Øystein Flesland, MD, PhD Head of Section Patient Safety Reporting and Learning Systems Unit Norwegian Knowledge Centre for the Health Services Oslo, Norway Plasma Effects on Microparticles, Coagulation and Vasoregulation Philip C. Spinella, MD FCCM Associate Professor of Pediatrics Division of Critical Care Medicine Director, Critical Care Translational Research Program Washington University School of Medicine St. Louis, Missouri USA Page 3 1/7/14

4 Pre-Hospital Plasma/TXA Experience Bjarnes Vikenes, MD Consultant, Emergency Medical Services and HEMS Bergen Department of Surgical Sciences Haukeland University Hospital LTC Elon Glassberg, MD Head, the Trauma and Combat Medicine Branch, IDF-MC Israel Defense Forces Medical Corps Tel HaShomer, Israel Anne Salliol, MD Commander French Military Blood Transfusion Center Clamart, France Plasma Session Discussion Moderator ret COL Donald Jenkins, MD Consultant, Division of Trauma, Critical Care and General Surgery Associate Professor of Surgery Trauma Medical Director Saint Mary s Hospital, Mayo Clinic Rochester, Minnesota USA LUNCH 1330 SESSION 6: RDCR CONCEPTS, PART 1 Moderator: Joseph Rappold, MD Associate Professor of Surgery Department of Surgery Temple University School of Medicine Philadelphia, Pennsylvania USA Update on starch based fluids Richard Weiskopf, MD Professor Emeritus, Department of Anesthesia University of California, San Francisco San Francisco, California USA Hypothermia prevention Jens Glørsen, MD Medical Officer, Nornavsoc Norway Break 1500 SESSION 7: RDCR CONCEPTS, PART 2 Moderator: Joseph Rappold, MD, FACS Associate Professor of Surgery Department of Surgery Temple University School of Medicine Page 4 1/7/14

5 Philadelphia, Pennsylvania USA Injectable hemostatic Adjuncts/FINTIC Study Marc Maegele, MD Professor, Department of Traumatology and Orthopedic Surgery Academic Hospital of the Witten Herdecke University Köln, Germany Advancements in Tourniquets John F. Kragh, Jr., MD COL (Ret.), MC, US Army Orthopedic Surgeon, Researcher US Army Institute of Surgical Research San Antonio, Texas, USA Octapharma Speaker TBD Octapharma 1900 Dinner Page 5 1/7/14

6 WEDNESDAY 0830 SESSION 8: CLINICAL TRIALS Moderator: Marc Maegele, MD Professor, Department of Traumatology and Orthopedic Surgery Academic Hospital of the Witten Herdecke University Köln, Germany INTRN Group Research Karim Brohi, MD Professor of Trauma Sciences Barts and the London School of Medicine Consultant in Trauma & Vascular surgery, Royal London Hospital London, UK TXA Study Updates Philip C. Spinella, MD FCCM Associate Professor of Pediatrics Division of Critical Care Medicine Director, Critical Care Translational Research Program Washington University School of Medicine St. Louis, Missouri USA COL Allan Murdock, MD Staff Surgeon of Trauma Critical Care University of Pittsburgh Medical Center Pittsburgh, Pennsylvania USA Whole Blood Trial Updates Geir Strandenes, MD Senior Medical Officer Norwegian Naval Special Operation Commando Researcher, Department of Immunology and Transfusion Medicine Haukeland University Hospital COL Alan Murdock, MD Staff Surgeon of Trauma Critical Care University of Pittsburgh Medical Center Pittsburgh, Pennsylvania USA Burn ICU patients as test bed for Bleeding Trials Heather Pidcoke, MD, PhD Research Physiologist Deputy Task Area Manager Coagulation and Blood Research Program US Army Institute of Surgical Research San Antonio, Texas USA BREAK Workshop Page 6 1/7/14

7 1045 SESSION 9: PLATELETS AND WHOLE BLOOD Moderator: LTC Andrew P. Cap, MD, PhD, FACP Chief, Coagulation and Blood Research Director, Clinical Research Fellowship Program US Army Institute of Surgical Research Medical Corps, US Army San Antonio, Texas USA Trauma-Induced Platelet dysfunction Mitchell Cohen, MD Associate Professor of Surgery Division of General Surgery Director of Acute Care Research University of California San Francisco, California USA Military pre-hospital platelet / whole blood plans Ivar Austlid, MD Anesthesiologist Norwegian Naval Medical Services Civilian pre-hospital platelet / whole blood plans ret COL Donald Jenkins, MD, FACS, DMCC Consultant, Division of Trauma, Critical Care and General Surgery Associate Professor of Surgery Trauma Medical Director Saint Mary s Hospital, Mayo Clinic Rochester, Minnesota USA Lunch 1315 SESSION 10: BLOOD BANK ISSUES Blood Bank Session Moderators: Einar Kristoffersen, MD, PhD Section of Immunology and The Blood Bank Department of Microbiology and Immunology The Gade Institute, University of Bergen Richard W. Olaussen, MD, PhD Section Leader Section of Blood Donation Blood Bank of Oslo Oslo, Norway What are acceptable universal blood products? prehospital vs. in hospital differences? Paul Ness, MD Director, Division of Transfusion Medicine Pathology and Oncology Johns Hopkins Baltimore, Maryland USA Page 7 1/7/14

8 Implementation and barriers to providing platelets and whole blood for prehospital resuscitation James R. Stubbs, MD Chair, Division of Transfusion Medicine Mayo Clinic Rochester, Minnesota USA Minding the Gap between prehospital and hospital transfusion support Heidi Doughty, MD Consultant in Transfusion Medicine NHS Blood and Transplant Birmingham, UK MIL-CIV collaboration in promoting RDCR Eilat Shinar, MD Director, Blood Services Magen David Adom in Israel Tel Aviv, Israel Registry Concept Philip C. Spinella, MD FCCM Associate Professor of Pediatrics Division of Critical Care Medicine Director, Critical Care Translational Research Program Washington University School of Medicine St. Louis, Missouri USA Nathan White, MD, MS Assistant Professor, University of Washington Dept. of Medicine Division of Emergency Medicine Seattle, Washington USA Future Direction / wrap up Geir Strandenes, MD Senior Medical Officer Norwegian Naval Special Operation Commando Researcher, Department of Immunology and Transfusion Medicine Haukeland University Hospital Page 8 1/7/14